Submitted for Publication: March 10, 2014; final revision received July 14, 2014; accepted August 18, 2014.
Published Online: December 30, 2014. doi:10.1001/jamapsychiatry.2014.2406.
Study concept and design: Sullivan, Oquendo, Parsey, Mann.
Acquisition, analysis, or interpretation of data: Sullivan, Oquendo, Milak, Miller, Burke, Ogden, Mann.
Drafting of the manuscript: Sullivan, Oquendo, Parsey.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Sullivan, Oquendo, Ogden.
Obtained funding: Oquendo, Parsey, Mann.
Administrative, technical, or material support: Oquendo, Miller, Parsey, Mann.
Study supervision: Sullivan, Oquendo, Milak, Burke, Parsey, Mann.
Conflict of Interest Disclosures: Dr Oquendo receives royalties from the Research Foundation for Mental Hygiene (RFMH) for commercial use of the Columbia Suicide Severity Rating Scale (C-SSRS); received financial compensation from Pfizer for the safety evaluation of a clinical facility; and has received unrestricted educational grants and/or lecture fees from AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Janssen, Otsuko, Pfizer, Sanofi, and Shire. Dr Oquendo’s family owns stock in Bristol-Myers Squibb. Dr Miller has received financial compensation for psychiatric evaluations of participants enrolled in medication studies sponsored by Pfizer and Orexigen Therapeutics. Dr Miller’s family owns stock in Johnson & Johnson. Drs Burke and Mann receive royalties from the RFMH for commercial use of the C-SSRS. Dr Mann has stock options from Qualitas Medical. No other disclosures were reported.
Funding/Support: This study was supported by grants MH40695, MH62185, and MH074813 from the US Public Health Service and a grant from the American Foundation for Suicide Prevention.
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.